ERBASAN, F. Et Al. 2023. EFFICACY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE.. EULAR 2023 , (Italy).

ERBASAN, F., ÖĞÜT, T. S., DİLBİL, M., NOKAY, M., TERZİOĞLU, M. E., & YAZISIZ, V., (2023). EFFICACY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE. . EULAR 2023, Italy

ERBASAN, FUNDA Et Al. "EFFICACY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE.," EULAR 2023, Italy, 2023

ERBASAN, FUNDA Et Al. "EFFICACY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE.." EULAR 2023 , Italy, 2023

ERBASAN, F. Et Al. (2023) . "EFFICACY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE.." EULAR 2023 , Italy.

@conferencepaper{conferencepaper, author={FUNDA ERBASAN Et Al. }, title={EFFICACY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE.}, congress name={EULAR 2023}, city={}, country={Italy}, year={2023}}